sulindac
Showing 1 - 19 of 19
Leukoplakia, Oral, Benign Tumors Trial in New York, Cochin, Trivandrum (sulindac, Placebo)
Completed
- Leukoplakia, Oral
- Benign Neoplasms
- sulindac
- Placebo
-
New York, New York
- +2 more
Oct 23, 2020
Desmoid Tumor Trial in Monrovia (tamoxifen citrate, sulindac, laboratory biomarker analysis)
Completed
- Desmoid Tumor
- tamoxifen citrate
- +2 more
-
Monrovia, CaliforniaChildren's Oncology Group
Feb 7, 2020
Inflammation, Cancer, Pain Trial in Tucson, Stony Brook (Sulindac)
Unknown status
- Inflammation
- +3 more
- Sulindac
-
Tucson, Arizona
- +1 more
Nov 28, 2018
Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Boston (Bevacizumab, erlotinib, Sulindac)
Terminated
- Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Bevacizumab
- +2 more
-
Boston, Massachusetts
- +1 more
Mar 15, 2017
Acute Myeloid Leukemia Trial in Boston (Cytarabine, Sulindac)
Withdrawn
- Acute Myeloid Leukemia
- Cytarabine
- Sulindac
-
Boston, MassachusettsMassachusetts General Hospital
Feb 15, 2017
Colon Cancer, Precancerous Condition, Rectal Cancer Trial in Rochester (oligofructose-enriched inulin, sulindac, )
Completed
- Colon Cancer
- +2 more
- oligofructose-enriched inulin
- +4 more
-
Rochester, MinnesotaMayo Clinic
Dec 28, 2016
Adenomatous Polyposis Coli Trial in Salt Lake City (Erlotinib, Sulindac, Placebo A)
Completed
- Adenomatous Polyposis Coli
- Erlotinib
- +3 more
-
Salt Lake City, UtahHuntsman Cancer Institute
May 10, 2016
Colorectal Cancer, Liver Metastasis, Colorectal Adenocarcinoma Trial run by the NCI (Sulindac, Placebo, Validate assays and
Terminated
- Colorectal Cancer
- +2 more
- Sulindac
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 22, 2015
Solid Tumor Trial in Rochester (sulindac, pharmacological study)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- sulindac
- pharmacological study
-
Rochester, MinnesotaMayo Clinic Cancer Center
Apr 27, 2015
Precancerous Condition Trial in Orange (, eflornithine, sulindac)
Completed
- Precancerous Condition
- placebo
- +3 more
-
Orange, CaliforniaUniversity of California Medical Center At Irvine-Orange Campus
Jan 12, 2015
Melanoma (Skin) Trial in Ireland (epirubicin HCl, sulindac, immunologic technique)
Completed
- Melanoma (Skin)
- epirubicin hydrochloride
- +2 more
-
Cork, Ireland
- +9 more
Dec 30, 2014
Focus of Study: Drug Response Biomarkers, Chemoprevention, Tumors Trial (difluoromethylornithine, Sulindac)
Withdrawn
- Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms
- difluoromethylornithine
- Sulindac
- (no location specified)
Jul 28, 2014
Precancerous Condition, Stage I NSCLC, Tobacco Use Disorder Trial in Canada, United States (sulindac, )
Completed
- Precancerous Condition
- +2 more
- sulindac
- placebo
-
Scottsdale, Arizona
- +5 more
May 7, 2014
Breast Cancer Trial in Philadelphia (docetaxel, sulindac)
Completed
- Breast Cancer
- docetaxel
- sulindac
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
May 5, 2014
Breast Cancer Trial in Tucson (sulindac, laboratory biomarker analysis)
Completed
- Breast Cancer
- sulindac
- laboratory biomarker analysis
-
Tucson, ArizonaArizona Cancer Center at University of Arizona Health Sciences C
May 1, 2013
Colorectal Cancer Trial in Houston (Acetylsalicylic acid (Aspirin), Sulindac, Ursodiol)
Terminated
- Colorectal Cancer
- Acetylsalicylic acid (Aspirin)
- +3 more
-
Houston, TexasM.D. Anderson Cancer Center at University of Texas
Jul 27, 2012
Colorectal Cancer Trial in New York (curcumin, rutin, quercetin)
Terminated
- Colorectal Cancer
- curcumin
- +3 more
-
New York, New YorkRockefeller University Hospital
Jan 26, 2011
Aberrant Crypt Foci Trial in New Brunswick (sulindac, curcumin)
Terminated
- Aberrant Crypt Foci
- sulindac
- curcumin
-
New Brunswick, New JerseyCancer Institute of New Jersey
Dec 10, 2009